Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone

被引:133
作者
Mukhina, S
Mertani, HC
Guo, K
Lee, KO
Gluckman, PD
Lobie, PE
机构
[1] Inst Mol & Cell Biol, Singapore 117609, Singapore
[2] Univ Lyon 1, CNRS, UMR 5123, F-69622 Villeurbanne, France
[3] Natl Univ Singapore, Dept Med, Singapore 119074, Singapore
[4] Univ Auckland, Liggins Inst, Auckland 1, New Zealand
[5] Univ Auckland, Natl Res Ctr Growth & Dev, Auckland 1, New Zealand
关键词
D O I
10.1073/pnas.0405881101
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We report here that autocrine production of human growth hormone (hGH) results in a phenotypic conversion of mammary carcinoma cells such that they exhibit the morphological and molecular characteristics of a mesenchymal cell, including expression of fibronectin and vimentin. Autocrine production of hGH resulted in reduced plakoglobin expression and relocalization of E-cadherin to the cytoplasm, leading to dissolution of cell-cell contacts and decreased cell height. These phenotypic changes were accompanied by an increase in cell motility, elevated activity of specific matrix metal loproteinases, and an acquired ability to invade a reconstituted basement membrane. Forced expression of plakoglobin significantly decreased mammary carcinoma cell migration and invasion stimulated by autocrine hGH. In vivo, autocrine hGH stimulated local invasion of mammary carcinoma cells concomitant with a prominent stromal reaction in comparison with well delineated and capsulated growth of mammary carcinoma cells lacking autocrine production of hGH. Thus, autocrine production of hGH by mammary carcinoma cells is sufficient for generation of an invasive phenotype. Therapeutic targeting of autocrine hGH may provide a mechanistic approach to prevent metastatic extension of human mammary carcinoma.
引用
收藏
页码:15166 / 15171
页数:6
相关论文
共 31 条
[1]   Reduced expression of plakoglobin correlates with adverse outcome in patients with neuroblastoma [J].
Amitay, R ;
Nass, D ;
Meitar, D ;
Goldberg, I ;
Davidson, B ;
Trakhtenbrot, L ;
Brok-Simoni, F ;
Ben-Ze'ev, A ;
Rechavi, G ;
Kaufmann, Y .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (01) :43-49
[2]   Focus on breast cancer [J].
Baselga, J ;
Norton, L .
CANCER CELL, 2002, 1 (04) :319-322
[3]   DISSECTING TUMOR-CELL INVASION - EPITHELIAL-CELLS ACQUIRE INVASIVE PROPERTIES AFTER THE LOSS OF UVOMORULIN-MEDIATED CELL CELL-ADHESION [J].
BEHRENS, J ;
MAREEL, MM ;
VANROY, FM ;
BIRCHMEIER, W .
JOURNAL OF CELL BIOLOGY, 1989, 108 (06) :2435-2447
[4]   Dissemination and growth of cancer cells in metastatic sites [J].
Chambers, AF ;
Groom, AC ;
MacDonald, IC .
NATURE REVIEWS CANCER, 2002, 2 (08) :563-572
[5]   Clinical use a of growth hormone receptor antagonist in the treatment of acromegaly [J].
Drake, WM ;
Parkinson, C ;
Besser, GM ;
Trainer, PJ .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2001, 12 (09) :408-413
[6]   Immunohistological analysis of E-cadherin, α-, β- and γ-catenin expression in colorectal cancer:: Implications for cell adhesion and signaling [J].
Ghadimi, BM ;
Behrens, J ;
Hoffmann, I ;
Haensch, W ;
Birchmeier, W ;
Schlag, PM .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (01) :60-65
[7]   Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis [J].
Hazan, RB ;
Phillips, GR ;
Qiao, RF ;
Norton, L ;
Aaronson, SA .
JOURNAL OF CELL BIOLOGY, 2000, 148 (04) :779-790
[8]   Inactivation of the E-cadherin-mediated cell adhesion system in human cancers [J].
Hirohashi, S .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (02) :333-339
[9]   Autocrine stimulation of human mammary carcinoma cell proliferation by human growth hormone [J].
Kaulsay, KK ;
Mertani, HC ;
Törnell, J ;
Morel, G ;
Lee, KO ;
Lobie, PE .
EXPERIMENTAL CELL RESEARCH, 1999, 250 (01) :35-50
[10]   The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behavior are mediated via the hGH receptor [J].
Kaulsay, KK ;
Zhu, T ;
Bennett, WF ;
Lee, KO ;
Lobie, PE .
ENDOCRINOLOGY, 2001, 142 (02) :767-777